Tourmaline Bio's total assets for Q1 2025 were $287.50M, a decrease of -6.96% from the previous quarter. TRML total liabilities were $7.63M for the fiscal quarter, a -14.68% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.